Table 1. Clinical characteristics of the study and control group.
Clinical characteristics | Study group (n=25) | Control group (n=25) | P |
---|---|---|---|
Male subjects | 18 (72.0) | 21 (84.0) | 0.306 |
Age, years | 65.5±16.4 | 64.1±15.4 | 0.757 |
Witnessed | 14 (56.0) | 14 (56.0) | 1.000 |
Bystander CPR | 17 (68.0) | 19 (76.0) | 0.529 |
Prehospital rhythm | 0.196 | ||
Shockable | 7 (28.0) | 3 (12.0) | – |
Unshockable | 18 (72.0) | 21 (84.0) | – |
Unknown | 0 (4.0) | 1 (4.0) | – |
Comorbidity | |||
Any comorbidities | 20 (80.0) | 20 (80.0) | 1.000 |
Hypertension | 13 (52.0) | 12 (48.0) | 0.777 |
Diabetes | 8 (32.0) | 7 (28.0) | 0.758 |
Coronary artery disease | 4 (16.0) | 9 (36.0) | 0.107 |
Cerebrovascular accident | 1 (1.0) | 4 (16.0) | 0.349 |
Chronic renal failure | 2 (8.0) | 2 (8.0) | 1.000 |
Chronic lung disease | 3 (12.0) | 1 (4.0) | 0.609 |
Chronic liver disease | 0 (0.0) | 1 (4.0) | 1.000 |
Active cancer | 1 (4. 0) | 5 (20.0) | 0.189 |
Initial rhythm | 0.147 | ||
VF/pulseless VT | 0 (0.0) | 2 (8.0) | – |
PEA | 2 (8.0) | 4 (16.0) | – |
Asystole | 23 (92.0) | 19 (76.0) | – |
Time factors | |||
Prehospital CPR time | 22.7±7.1 | 21.8±9.2 | 0.720 |
Data are presented as n (%) or mean with standard deviation. CPR, cardiopulmonary resuscitation; VF, ventricular fibrillation; VT, ventricular tachycardia; PEA, pulseless electrical activity.